BCEIE › News › OPTIEMUS

Order win

Optiemus Infracom: Intimation regarding entering into a loan agreement with GDN Enterprises Private Limited, Wholly Owned…

Optiemus Infracom (BSE: OPTIEMUS) said it has received an order. The company is valued at about ₹6,075 crore.

BCEIE News Desk · Published 27 Oct 2026, 05:59 pm IST · Filing received 27 Oct 2026, 05:42 pm IST

What happened

Optiemus Infracom (BSE: OPTIEMUS) informed the stock exchanges on 27 October 2026 at 05:42 PM that it has received an order.

Company snapshot

Optiemus Infracom is a small-cap company in the Telecommunication sector, with a market value of about ₹6,075 crore.

The stock last traded at ₹673.7, against a 52-week range of ₹288–₹924.9 (27.2% below the high).

Before this filing the shares had moved −18.7% over the month and +10.4% over three months. Average daily turnover over the last 20 sessions was about ₹98.42 crore.

Promoters held 71.40% at the end of Q2 FY27, down 0.14% points from the previous quarter; 2.56% of promoter shares were pledged. Foreign institutions owned 3.31% and domestic institutions 2.40%.

Quarterly results (consolidated, ₹ crore)
QuarterRevenueNet profitEPS (₹)
Q1 FY2643514.51.67
Q2 FY2641816.81.92
Q3 FY2643012.21.39
Q4 FY2648522.52.56
Q1 FY2788321.22.39

What history shows

BCEIE's records show 1 previous order win filing from the company since May 2026.

Across 61 similar disclosures by other Telecommunication companies, shares moved +0.8% on average the next day and +1.9% over five days; 56% of them rose the next day.

Market-wide, 2,047 order win filings with an impact score of 50 or more saw an average next-day move of +0.8%, with 53% rising.

Past reactions describe what happened before; they are not a forecast.

What to watch

  • Execution progress and revenue recognition from this order in the coming quarters.

In the news

Recent coverage elsewhere (links open the original publisher):

Source

Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.